Tesla Motors Inc. (NASDAQ:TSLA) the reputed manufacturer of electric cars that saw a fourfold growth in its stock last year has surprisingly been rated as junk by Standard & Poor’s because the long term prospects of the company are of ‘considerable uncertainty,’ believe the rating agency. Tesla Motors Inc (NASDAQ:TSLA) net profit margin is -6.50% and weekly performance is 7.89%. On last trading day company shares ended up $211.56. Analysts mean target price for the company is $224.83. Tesla Motors Inc (NASDAQ:TSLA) distance from 50-day simple moving average (SMA50) is 1.77%.
Leerink Swann hoisted their price target on shares of Novartis AG (ADR) (NYSE:NVS) from $93.00 to $104.00 in a research note issued on Wednesday. The firm currently has an “outperform” rating on the stock. Leerink Swann’s price objective suggests a potential upside of 15.20% from the stock’s previous close. Novartis AG (ADR) (NYSE:NVS) shares advanced 0.08% in last trading session and ended the day on $90.28. Gross Margin is 66.50% and its return on assets is 7.80%. Novartis AG (ADR) (NYSE:NVS) quarterly performance is 11.36%.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has announced that the European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon BV, Mylan and an unidentified third party. Teva’s US patent for Copaxone expired four days ago on April 28th, but to date no company has obtained US Food and Drug Administration (FDA) approval for generic Copaxone. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares moved up 0.23% in last trading session and was closed at $51.89, while trading in range of $50.98- $52.27. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) year to date (YTD) performance is 31.33%.
0n May 22, At a meeting today with members of the investment community, senior leaders from the Medical Devices and Diagnostics (MD&D) segment of Johnson & Johnson (NYSE:JNJ) will outline plans to improve patient outcomes and expand their market leadership through innovative products, new business models and a significant focus on fast-growing emerging markets. Johnson & Johnson (NYSE:JNJ) ended the last trading day at $100.81. Company weekly volatility is calculated as 0.84% and price to cash ratio as 9.70. Johnson & Johnson (NYSE:JNJ) showed a positive weekly performance of 0.87%.
On May 17, IAC/InterActiveCorp (NASDAQ:IACI) has been given a consensus rating of “Hold” by the fifteen analysts that are covering the stock, American Banking News.com reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $70.69. IAC/InterActiveCorp (NASDAQ:IACI) net profit margin is 8.90 % and weekly performance is 2.25%. On last trading day company shares ended up $ 64.41. Analysts mean target price for the company is $74.53. IAC/InterActiveCorp (NASDAQ:IACI) distance from 50-day simple moving average (SMA50) is -4.77%.